J&J Discloses Favorable Covid Booster Data

New data released by Johnson & Johnson says the COVID vaccine is more effective when given as a two-dose regime,.<br />A second shot is given 56 days after the first provided 75 per cent protection against symptomatic Covid in a global clinical trial, with that level rising to 94 per cent in the United States.<br />It was 94 per cent effective in preventing severe or critical Covid at least 14 days post final vaccination in America.<br />The data is positive news for the almost 15 million Americans who received one dose of the J&J vaccine but have been left in the dark about if and when they might need a booster.